Gland Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
1,579.60
1,582.55
1,426.58
1,246.24
823.95
Other Income Qtr Cr42.1537.3953.1637.5438.94
Operating Revenues Qtr1,537.451,545.161,373.421,208.69785.01

*All values are in Cr.

Operating Expenses Qtr
1,178.80
1,188.77
1,049.35
914.74
616.59
Operating Profit Qtr
358.65
356.39
324.08
293.95
168.42
EBIDT Qtr Cr
400.80
393.78
377.23
331.50
150.90
Depreciation Qtr
92.61
105.34
81.30
65.32
37.54
Net Profit Qtr
192.42
191.86
194.08
194.10
78.68
Basic EPS Qtr
11.68
11.65
11.78
11.79
4.78
Open Demat Account
or Resume your Application
+91 -

personImage